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ABSTRACT 
The importance of thyroid hormone (TH) for mental health has been known for decades. 
With the identification of the thyroid hormone receptors α and β (TRα, TRβ), TR dependent 
mechanisms involved in brain development were investigated, identifying TRα1 as the main 
TR isoform in the brain. However, the lack of reliable antibodies has hampered the 
identification of TRα1 expressing cell types and TRα1 target genes. Here, we used two 
mouse lines to unravel TRα1 action in the developing brain. Firstly, using the TRα1-GFP 
mice circumvented the need for specific TRα1 antibodies in the study of TRα1 expression 
and target genes. Secondly, the TRα1+m mice which express a dominant negative TRα1 
allowed the study of a receptor mediated hypothyroidism that furthermore can be ameliorated 
by supraphysiological doses of TH. These mice exhibit a delayed differentiation of 
parvalbumin expressing (PV+) GABAergic interneurons in the neocortex.  
In paper I we describe the expression of TRα1 in the developing and mature brain of TRα1-
GFP mice. TRα1 expression occurred in postmitotic neurons, which persisted in most mature 
neurons and in the glial tanycytes in the hypothalamus; the postnatal cerebellum however 
showed a transient expression in Purkinje cells. This mouse model was further utilized in 
paper II to identify TRα1 target genes in the TRα1-GFP mice by establishing a ChIP assay. 
This enabled us to enrich specifically for TRα1-bound DNA with GFP antibodies and to use 
wildtype chromatin as perfect background control. In paper III and IV this method led to 
identification of further target genes. Paper III we revealed a tissue specific regulation of 
carbonic anhydrase 4 (Car4) expression by TH. In brain and liver, Car4 was downregulated in 
TRα1+m mice, which could not be normalized by TH treatment, indicating the importance of 
proper TRα1 signaling during development for establishing the Car4 expression level in the 
adult. In contrast, renal Car4 expression was unaltered in the mutants but downregulated in 
response to TH treatment, revealing a suppressive function of renal TH. In paper IV, we 
investigated the role of TRα1 in developing PV+ cells and showed that TRα1 does not 
interfere with proliferation or migration of these cells but instead postpones their final step of 
differentiation. This was accompanied by a reduced expression of the neurotrophin NT-3. In 
summary, we described the temporal and spatial expression of TRα1 in the brain and 
established a method to reliable identify TRα1 target genes which is crucial to further 
understand the mechanism involved in TH dependent brain development. 
 
POPULAR SCIENCE - GERMAN  
Müdigkeit, Abgeschlagenheit und Konzentrationsschwäche werden leicht mit 
unzureichendem Schlaf, falschem Essen oder zu wenig Bewegung assoziiert, aber oft verbirgt 
sich dahinter jedoch eine Fehlfunktion der Schilddrüse. Eine Schilddrüsenunterfunktion, die 
dazu führt, dass der Körper unzureichend mit Hormonen versorgt wird, kann jedoch leicht 
mit Schilddrüsenhormon-Supplementen behandelt werden. Tritt diese Unterversorgung 
allerdings während der Schwangerschaft auf, sind irreversible neurologische Schädigungen 
im Neugeboren häufig. Darüberhinaus gibt es eine angeborene Schilddrüsenunterfunktion, 
den sogenannten kongenitalen Hypothyroidismus, die zu neurologische Schädigungen wie 
zum Beispiel einem reduzieren IQ führen kann, wenn sie nicht rechtzeitig erkannt und 
behandelt wird. Bislang ist allerdings noch unzureichend verstanden, welche Regionen und 
Zellen im Gehirn genau davon betroffen sind. Mit einem Mausmodell konnten wir nun 
zeigen, dass sich spezielle inhibierende Zellen, die sogenannten Parvalbumin-Neurone, im 
Gehirn nicht richtig entwickeln wenn nur unzureichend Schilddrüsenhormon zur Verfügung 
steht. Ein Verlust dieser Zellart ist assoziiert mit Epilepsie und Autismus.  
Der genau Wirkungsmechanismus der Schilddrüsenhormone auf zellulärer Ebene ist 
ebenfalls nicht geklärt. Gründe dafür sind zum einen die fehlenden Daten über die 
zellspezifische Verteilung der Schilddrüsenhormon – Bindungsstellen (Rezeptoren)  im 
Gehirn und zum anderen das lückenhafte Wissen über die involvierten Gene, die von den 
Hormonen in ihrer Aktivität reguliert werden. Meine Doktorarbeit fokussierte sich daher auf 
die Aufklärung des Wirkmechanismus der Schilddrüsenhormonen in der Entwicklung der 
inhibierenden Zellen. Wir konnten zeigen, dass die im Gehirn vorherrschende Form des 
Schilddrüsenhormonrezeptors Alpha 1 in allen Nervenzellen zu finden ist. Außerdem 
konnten wir eine neue Methode etablieren, mit deren Anwendung wir neue Zielgene der 
Schilddrüsenhormone in Gehirn identifizieren konnten. Aufbauend auf diesen Erkenntnissen 
konnten wir letztendlich einen Wirkungsmechanismus vorzuschlagen, wie 
Schilddrüsenhormone die Reifung der inhibierenden Zellen auf molekularer Ebene 
kontrollieren.  Mit den erhaltenen Ergebnissen könnte eine neue Behandlungsstrategie für 
Patienten mit schilddrüsenhormonbedingten neurologischen Defekten entwickelt werden. 
Darüberhinaus trägt die Arbeit dazu bei, die immense Bedeutung der Schilddrüsenhormone 
in der Gehirnentwicklung zu unterstreichen und somit die irreversiblen Schädigungen durch 
unerkannte Schilddrüsenprobleme in der Schwangerschaft und in Neugeborenen zu 
vermeiden. 
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1 INTRODUCTION 
Fatigue, concentration deficits, weight gain and mood disorders are often correlated with a 
lack of sleep, unhealthy food and work overload. However, these are also typical symptoms 
for a shortage of thyroid hormone, a condition called hypothyroidism. Depending on degree 
and temporal onset, hypothyroidism causes a plethora of symptoms ranging from metabolic 
to behavioral phenotypes, growth and mental retardation, locomotor disorders, anxiety, mood 
disorders and heart failure. Most effects of TH are mediated by the nuclear thyroid hormone 
receptors α and β (TRα, TRβ), with TRα1 being the predominant TR isoform in the brain. 
Even though the importance of TH for brain development and function has been described 
decades ago, a lack of reliable TR antibodies has hampered the identification of many TH 
target genes and the unraveling of molecular mechanism causing the described symptoms. 
My thesis therefore focused on understanding the role of TRα1 in brain development by 
detecting TRα1 on the cellular level, identifying novel TRα1 target genes and unraveling the 
role of TRα1 in the maturation of GABAergic interneurons.  
 
1.1 THYROID HORMONES  
In humans, three to four weeks after gestation the thyroglossal duct develops at the base of 
the tongue and atrophies into thyroid tissue to create the two lobes of the thyroid gland. 
Follicular cells build the endocrine unite of the thyroid gland and are responsible for the 
production of thyroid hormone (TH).  
 
1.1.1 Production and release of thyroid hormones 
In the follicles tyrosine residues on thyroglobulin are iodinated to synthesize two kinds of 
thyroid hormones, T4 (3,3’,5,5’– tetraiodothyronine) and T3 (3,3’,5- triiodothyronine) 
negative feedback system regulated by the hypothalamus-pituitary-thyroid (HPT) axis 
controls the production and secretion of TH. The hypothalamus secretes thyrotropin-releasing 
hormone (TRH), which stimulates the pituitary to release thyrotropin-stimulating hormone 
(TSH). TSH in turn activates the thyroid gland to produce and secrete TH into the circulation 
(Fig. 1). Both T3 and T4 serve as negative feedback regulator on TSH and TRH (Yen, 2001; 
Bauer et al., 2008), e.g. decreased TH levels increase TRH and TSH secretion leading to 
higher production of TH. The majority of TH secreted by the thyroid gland is T4, which is 
regarded as a pro-hormone. This pro-hormone is peripherally converted into the biological 
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active form T3 by tissue specific deiodinases; this extrathyroidal synthesis of T3 accounts for 
approximately 80% (Kohrle, 1999; Sandler et al., 2004).  
 
Figure 1: The HPT axis. TRH and TSH stimulate T4 and T3 release, whereas T4 and T3 send a 
negative feedback to inhibit further TRH and TSH expression. 
 
1.1.2 Deiodinases  
Specific proteins transport TH across the cell membrane. The two major families are the 
monocarboxylate transporters (e.g. MCT8) and organic-anion transporter polypeptides (e.g. 
OATP1c1) (Friesema et al., 2003; Friesema et al., 2008; Schweizer & Kohrle, 2013). In the 
cell, deiodinases regulate T3 availability in response to TH levels in a tissue and spatial 
dependent manner. They either activate T4 by removing iodine from the outer ring to produce 
T3 (DIO1, DIO2) or inactivate T4 by facilitating the inner ring deiodination (DIO1, DIO3) to 
generate reverse T3 (rT3) (Bianco & Kim, 2006). DIO2 converts T4 to T3 in the central 
nervous system (CNS), including hypothalamus, pituitary and cortex, where it is responsible 
for 75% of the nuclear T3 (Crantz et al., 1982). The inactivating DIO3 is mostly expressed in 
the placenta, uterus and CNS (Kohrle, 1999; St Germain et al., 2005). Lastly, DIO1 with 
affinity to both rings is expressed in liver, kidney, thyroid and pituitary (Bates et al., 1999; 
Bianco et al., 2002) (Fig. 2). However, studies on mice lacking the DIO2 gene and 
endogenously low levels of DIO1 demonstrated normal T3 and increased serum T4 and TSH 
levels, indicating the presence of an compensating mechanism most likely due to an adaption 
of thyroidal TH production (Bianco & Kim, 2006).  
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Figure 2: Structures of T4, T3 and reverse T3 with deiodinases catalyzing activation or inactivation of 
the hormone.  
 
1.2 THYROID HORMONE RECEPTORS  
In the 19th century hypothyroid patients were treated with sheep thyroid extract to ameliorate 
their symptoms, but the active components in the extract was not known until 1915 when 
thyroid hormone was isolated and crystalized by Kendall. However, it took another 40 years 
to identify T3, the active form (Gross & Pitt-Rivers, 1952). Its vital function was well 
acknowledged but it was not apparent how the hormone exerted its function (Hamdy, 2002). 
Finally, in 1986 the first thyroid hormone receptor isoforms were identified, which allowed 
research on their mechanism of action in the cell (Sap et al., 1986; Weinberger et al., 1986).  
 
1.2.1 Thyroid hormone receptors and gene expression  
T3 exerts its function through binding to the thyroid hormone receptors (TRs) α and β.  TRs 
are encoded by the Thra and Thrb genes (Sap et al., 1986; Weinberger et al., 1986; Koenig et 
al., 1988), alternative splicing give rise to four isoforms: the ligand binding TRα1, TRβ1, 
TRβ2 and the non-ligand binding TRα2 (Fig. 3A) (O'Shea & Williams, 2002).  
 
Figure 3A: Thyroid hormone receptors. Schematic representation of TR isoforms with functional 
domains including DNA binding and T3 binding domain as well as T3 binding ability.  
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TRs show similar structural organization with an amino-terminal A/B domain, a ligand 
binding C-domain and a DNA binding N-domain (Yen, 2001). However, the TRβ isoforms 
differ in their amino-terminal regions, whereas the divergent carboxy-terminal region of 
TRα2 prevents ligand binding and its function is poorly understood (Moran & Chatterjee, 
2015). TRs belong to the family of nuclear receptors and are ligand modulated transcription 
factors. They usually bind as heterodimers in association with retinoid X receptor (RXR) to 
thyroid response elements (TRE) of target genes and generally activate their transcription 
upon ligand binding (Fig. 3B).  
Non-liganded receptors recruit co-repressors such as Ncor, SMRT and Alien and bind histone 
deacetylases to silence positively regulated target genes. Ligand binding then leads to 
conformational changes resulting in the release of co-repressors and the recruitment of co-
activators, such as SRC-1, TIF-2, CBP, with subsequent histone acetyltransferase binding and 
gene activation (Fig. 3B) (Koenig, 1998; Moran & Chatterjee, 2015). It can be said that in the 
euthyroid organism, the circulating level of TH balances transcriptional repression and 
activation to achieve an optimal target gene expression. Negatively regulated genes, e.g. TRH 
and TSH, are repressed upon ligand binding and activated by the apo-receptor; however not 
many negatively regulated genes have been identified so far and the molecular mechanisms 
remain obscure (Chin et al., 1998; Costa-e-Sousa & Hollenberg, 2012).  
          
Figure 3B: Repression and activation of a positively regulated gene. TR and RXR bind as a 
heterodimer to TRE. Binding of Ncor and other co-factors lead to target gene repression. T3 binding 
initiates recruitment of co-activators such as SRC-1 and activation of gene expression.  
 
TRs are ubiquitously expressed, with TRα1 being the most abundant isoform in the brain, 
bone, heart and gastrointestinal tract. In contrast, TRβ1 is the predominant isoform in kidney 
and liver, while TRβ2 expression is limited to the hypothalamus, pituitary, eye and inner ear 
(Brent, 1994; Forrest et al., 1996a). 
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1.2.2 Characteristics of thyroid hormone response elements  
In order to elucidate the molecular mechanism causing the syndromes related to TH 
dysregulation, target genes need to be identified. However, the high variety of sequences and 
the lack of reliable TR antibodies have hampered the detection of thyroid hormone response 
elements (TRE) and consequently the identification of thyroid hormone target genes. In 
previous studies, Thompson et al. used gel shift assays to narrow down the putative TRE 
sequence for hairless, a protein known to be regulated by TH (Thompson, 1996). Gel shift 
assays were performed with radioactive labeled DNA, RXR and TR. Fragments that were 
found to bind the labeled complex were subcloned and reloaded to a gel shift assay. This was 
performed multiple times until a TRE sequence was identified (Thompson & Bottcher, 1997). 
Another TRE was described using co-immunoprecipitation with anti-TR antibodies and 
footprint analysis. This technique also helped to determine the TRE in RC3, a gene 
implicated among others in synaptic plasticity and regulated by TH (Martinez de Arrieta et 
al., 1999). Although neither method allowed to conclude which TR isoform binds to the 
TREs, they helped together with other studies to characterize TREs. However, genome wide 
analyses in neural cells revealed partly overlapping target genes but also TR isoform specific 
gene transcription (Chatonnet et al., 2013), which was in line with previous observation in 
TR overexpressing HepG2 cells (Chan & Privalsky, 2009). Tissues expressing both isoforms, 
revealed distinct phenotypes when one or the other isoform was blocked. This finding 
suggested different gene repertoires for TRα1 and TRβ in one tissue (Winter et al., 2006), 
which was later supported when a receptor specific preference of T3 target genes was 
identified (Chatonnet et al., 2013).  
However, from previous studies it can be summarized that, TREs are generally located 
upstream of the promoter (Chatterjee et al., 1989; Carr et al., 1992; Bigler & Eisenman, 
1995; Yen, 2001) and that the consensus hexamer half-site for TREs is encoded by 
(G/A)GGTC(C/G)A (Cheng et al., 1987). Most target genes possess more than one half-site 
which is organized as direct, inverted or everted repeats with an optimal spacing of zero, four 
or six nucleotides respectively (Fig. 4). The majority of described TREs are direct repeats 
with a spacing of four nucleotides (DR4), such as in the promotor of kruppel like factor (klf9) 
(Denver & Williamson, 2009; Paquette et al., 2014).  
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     Figure 4: Sequences and organization of thyroid hormone response elements.  
 
1.3 THYROID HORMONE DISORDERS  
In a healthy individual serum TH levels are stable and fine balanced via the HPT axis. 
However, iodine deficiency, autoimmune disorders or pregnancy can cause dysregulation of 
TH levels. Given the ubiquitous expression of TRs it is not surprising that alterations in TH 
levels lead to adverse affect in the body. 
 
1.3.1 Hypothyroidism 
A lack of TH caused by e.g. insufficient iodine intake or the autoimmune disorder 
Hashimoto’s disease (loss of follicular cells) leads to weight gain, cold sensitivity, tiredness 
and mood disorders, symptoms that easily can be associated with other dysfunctions. 
However, low TH levels can be stabilized with hormone supplementation, when identified. 
During pregnancy the embryo depends largely on TH supply from the mother as TRs can 
already be detected in the fetal brain at 9-12 weeks of gestation, i. e. before endogenous TH 
production is established at around 17-19 weeks of gestation (de Escobar et al., 2004; Chan et 
al., 2009). Even though it was shown in numerous studies that already a mild reduction of TH 
levels during pregnancy leads to neuronal alterations in the brain, mental retardation and 
growth defects in the offspring (Haddow et al., 1999; Pop et al., 1999; Utiger, 1999; Auso et 
al., 2004; de Escobar et al., 2004; Lazarus et al., 2012) a general screening for subclinical 
hypothyroidism is currently not advised, as there are only limited data on the outcome of the 
treatment of mild hypothyroidism during pregnancy (Lazarus et al., 2014). This however is 
controversially discussed and about 40% of endocrinologists in Europe test TH levels during 
pregnancy routinely (Vaidya et al., 2012), but the number might be different for 
gynecologists.  
 
Consensus half-site (G/A)GGTC(C/G)A  
Direct Repeat AGGTCANNNNAGGTCA 
Everted Repeat TGACCTNNNNNNAGGTCA 
Inverted Repeat AGGTCATGACCT  
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Congenital hypothyroidism  
Also, hypothyroidism can occur in the newborn child, a syndrome called congenital 
hypothyroidism. This disease is mostly caused by deficits in thyroid gland development or 
thyroid hormone production, and leaves the child mentally retarded with motor dysfunctions, 
short statue, obesity and delayed overall development, if the condition remains untreated in 
the first weeks of live (Bernal, 2007; Rastogi & LaFranchi, 2010; Krude et al., 2015). 
Fortunately, thyroid TSH levels in newborns are routinely tested in most developed countries 
(Horn & Heuer, 2010), and timely treatment prevents mental retardation entirely (Gruters & 
Krude, 2012). However, also mutations in the T3 transporter MCT8 cause severe mental and 
motor retardations including inability to speak or hear and poor head control (Schwartz & 
Stevenson, 2007). As the T3 transport is inhibited, the T3 serum levels are increased. 
Consequently, children suffer additionally of hyperthyroidism leading to hypermetabolism, 
tachycardia or anorexia; unfortunately, a treatment of this disease in not yet established 
(Krude et al., 2015). 
 
1.3.2 Hyperthyroidism  
Not only reduced levels of TH have consequences for health and wellbeing, also the 
increased production of TH leads to disease. Goiter and adenomas can cause an excessive TH 
production, although the quite common autoimmune Grave’s disease causes the majority of 
the hyperthyroidism related diseases (Nathan & Sullivan, 2014). This disorder involves 
autoimmune antibodies that stimulate the TSH receptor, thereby increasing the production 
and secretion of TH. Elevated TH levels lead to symptoms such as anxiety, restlessness, 
depressive disorders, impaired concentration and decreased appetite (Bauer et al., 2008). 
During pregnancy hyperthyroidism increases the risk for miscarriages, maternal heart failure 
and hypertension as well as growth retardation and increased risk for congenital 
hypothyroidism in the child (Nathan & Sullivan, 2014). The latter is due to an impaired 
development of the HPT axis in a hyperthyroid environment (Kempers et al., 2003). Like 
hypothyroidism, hyperthyroidism is not always immediately identified by physicians, as the 
symptoms are quite vague and blood test are needed. Once identified, TH level can be 
corrected by anti-thyroid drugs that reduce TH production. 
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1.4 MOUSE MODELS WITH MUTATION IN THYROID HORMONE RECEPTOR 
ISOFORMS 
For decades it has been an enigma how thyroid hormones exerted their functions.  With the 
identification of thyroid hormone receptors (Sap et al., 1986; Weinberger et al., 1986; Koenig 
et al., 1988) researchers became eager to elucidate the function of those receptors.  
Subsequent creation of several mouse models with mutations in different thyroid hormone 
receptor alleles revealed a variety of phenotypes.  
 
1.4.1 Phenotypes of various TR knock out mice  
Studies on various TR knockout animals revealed TR specific roles in development and 
physiology of target tissues. In general, TRα1 was found to be crucial for postnatal 
development and cardiac function, whereas TRβ is mainly involved in inner ear and retina 
development, liver metabolism and regulation of thyroid hormone (Flamant & Samarut, 
2003).  
The phenotype of mice lacking both of TRβ1 and TRβ2 expression is characterized by goiter, 
deafness as well as high levels of TSH and TH, indicating an involvement of TRβ in the HPT 
axis (Forrest et al., 1996b). However, TRβ2 knockout mice exerted normal hearing and only 
slightly increased T3 and TSH levels, indicating a predominant function of TRβ1 in hearing 
development and pituitary control, with the latter being modulated by TRβ2 (Ng et al., 2001). 
Additional, TRβ2 contributes to vision development by regulating late stage differentiation of 
M-cones, consequently TRβ2 knockout led to M-cones loss (Ng et al., 2001; Roberts et al., 
2006). 
TRα1 knockout mice with preserved TRα2 function showed low heart rate and reduced body 
temperature (Wikstrom et al., 1998). Mice lacking only TRα2 were viable with a mixed 
hyper- and hypothyroid phenotype including increased fat mass, growth retardation but 
reduced body weight, elevated heart beat and higher body temperature. As the TRα2 
knockout lead to overexpression of TRα1, the phenotype was ascribed to the increased TRα1 
action (Salto et al., 2001).  
Finally, TRα1/TRβ knockout mice exhibit a hyperactive HPT axis, poor female fertility, 
retarded growth and bone development, i.e. characteristics not seen so prominently in the 
single knockout mice indicating the existence of common and distinct pathways for the TR 
isoform. Interestingly, due to the lack of the receptors, the endogenous excess of TH in the 
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double knockouts does not lead to a hyperthyroid phenotype. Moreover, induced 
hypothyroidism in those mice had no affect on their phenotype either, demonstrating that 
TRα1 and TRβ are the only T3 responsive receptors, and that TRα2 may only have a 
modulating function (Gothe et al., 1999).  
 
1.4.2 Dominant negative TRα1 
Since a lack of TRs caused a milder phenotype than the lack of TH as seen for example in 
cretinism, it was postulated that the non-ligand receptor suppresses gene expression (Gothe et 
al., 1999; Morte et al., 2002). As abolished TH binding to TRβ leads to the condition of 
resistance to thyroid hormone (RTH), it became of great interest to study a similar mutation 
in TRα1. Since no patients with mutations in TRα1 had been found before 2012, it was 
speculated that the phenotype of RTHα patients is either too mild for diagnosis, lethal leading 
to abortions, or difficult to associate with a thyroid hormone receptor disorder. To study the 
outcome of a TRα1 aporeceptor, Björn Vennström’s group introduced a mutation into the 
TRα1 locus originally identified in the TRβ gene (Adams et al., 1994). Tinnikov and 
colleagues changed arginine to cysteine in the ligand-binding domain of TRα1 leading to a 
10-fold reduced affinity to T3, leaving the receptor in a non-ligand state (TRα1R384C). The 
mutant receptor acts in a dominant negative manner and can be reactivated by 
supraphysiological doses of TH (Tinnikov et al., 2002). Most homozygous mice die shortly 
after birth for unknown reasons, whereas heterozygotes (TRα1+m) generally survive to 
adulthood. The postnatal phenotype of these TRα1+m mice is low birth weight and a retarded 
development including ossification, eye opening, tooth eruption, maturation and puberty. TH 
administration throughout pre- and postnatal development relieved those symptoms 
(Tinnikov et al., 2002). Adult mice show slightly reduced heart rate and reduced blood 
pressure (Mittag et al., 2010b). They are hyperphagic, hypermetabolic and have a 10-15% 
reduced body weight due to decreased white adipose tissue (Sjogren et al., 2007). Endocrine 
markers in adults such as TSH were found to be normal to elevated in adults, T4 was low to 
normal, whereas T3 showed no alteration (Tinnikov et al., 2002). Neurologically, TRα1+m 
mice exhibit anxiety and reduced cognition, which can be normalized with T3 treatment in 
adulthood (Venero et al., 2005). They are resistant to chemical induced seizures, but 
susceptible to audiogenic seizures (Hadjab-Lallemend et al., 2010). Moreover, they show 
reduced grip strength, abnormal gait, everted hind paws and poor limp coordination similar to 
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what is seen in cretinism. Reduced grip strength was ameliorated by the combined fetal and 
postnatal TH treatment (Wallis et al., 2008).  
Interestingly, other mouse models with similar mutations in the ligand-binding domain show 
somewhat different phenotypes, ranging from dwarfism to near normal growth and from lean 
to obese mice. The differences might be explained by the location of the mutation, which 
may alter cofactor binding (Liu et al., 2007; Mittag et al., 2010b). Consequently, Liu et al. 
demonstrated a mutation dependent interaction with peroxisome proliferator activated 
receptor α (PPARα), a regulator of lipid metabolism. Mice harboring a slightly different 
point mutation in TRα1 (TRα1P398H) show visceral obesity, whereas TRα1R384C mice are 
lean. Interestingly, TRα1P398H reduced the binding of PPARα to its response elements 
compared to wildtype TRα1 whereas TRα1R384C did not affect PPARα binding and 
showed similar transactivation properties as the wt TRα1 (Liu et al., 2007). These findings 
explain at least partly the diverse metabolic phenotypes and demonstrate the mutation 
dependent transactivation of target genes. 
 
1.5 PATIENTS WITH RESISTANCE TO THYROID HORMONE  
Mutations in the ligand-binding domain of TRs lead to tissue-specific hyposensitivity 
towards TH. For decades only patients with mutations in TRβ were found, as guidelines to 
identify TRα1 patients were not available, until recently the first TRα1 patients were 
characterized (Bochukova et al., 2012; Moran et al., 2013; van Mullem et al., 2013; Moran & 
Chatterjee, 2015). Now we distinguish between two disorders: resistance to thyroid hormone 
α (RTHα) or resistance to thyroid hormone β (RTHβ). In both syndromes the mutated 
receptors exert a dominant negative function over the wildtype receptor, hence, inhibiting its 
function and repressing the transcription of most genes that are normally activated by ligand 
binding. This is most likely caused by failure of corepressor dissociation by the dominant 
negative receptor (Yoh et al., 1997; Moran & Chatterjee, 2015). 
 
1.5.1 Resistance to thyroid hormone β 
3000 individuals with mutation in TRβ have been identified to date (Dumitrescu & Refetoff, 
2013). The autosomal inherited mutation concerns the ligand binding domain of TRβ and 
leads to impaired or abolished binding of T3 to TRβ, leaving TRβ in the aporeceptor stage 
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and, hence, suppressing the transactivation of positively regulated genes. However, the 
negatively regulated gene TSH is increased in RTHβ patients regardless of their elevated TH 
levels. Since transactivation of TSH is initiated by the aporeceptor, the inability of the mutant 
receptor to bind TH leads to an overexpression of TSH, which demonstrates the failure of the 
mutant receptor to regulate gene expression (Mittag et al., 2010b; Dumitrescu & Refetoff, 
2013).  
RTHβ patients show heterogeneous symptoms, but goiter, tachycardia, attention deficit 
hyperactivity disorder (ADHD), learning disability and developmental delay are the common 
clinical signs (Refetoff et al., 1993).  
 
1.5.2 Resistance to thyroid hormone α 
The first case of RTHα was described in 2012, to date there are 14 reported patients from 10 
families (Moran & Chatterjee, 2015), exhibiting e.g. de novo mutations (Bochukova et al., 
2012; Moran et al., 2013), or inherited RTHα (van Mullem et al., 2013). Depending on the 
mutation T3 binding can either be diminished or abolished, but both cases lead to a dominant 
negative apo- TRα1. Hallmarks of the syndrome are hypothyroid features such as short 
statue, delayed bone age, impaired ossification, bradycardia, severe constipation, 
macrocephaly, reduced muscle strength, developmental delay and cognitive impairment, with 
normal TH and TSH levels, low rT3 and subnormal T3/T4 ratio. In some cases T4 treatment 
improved constipation, metabolic rate, general activity, but showed no effect on 
developmental delay, growth rate or bradycardia (Bochukova et al., 2012; Moran et al., 2013; 
van Mullem et al., 2013). These observations integrate well with our findings in TRα1+m 
mice: developmental delay was rescued by pre- and postnatal treatment with high doses of 
TH, whereas postnatal treatment was not sufficient to ameliorate growth retardation or 
reduced heart rate (Tinnikov et al., 2002). Interestingly, whole genome sequencing of patients 
with autism spectrum disorders identified a patient with a R384C mutation in TRα1, identical 
to the mutation in our TRα1+m mouse strain (Yuen et al., 2015).  Unfortunately, no further 
data about that patient are available to date. Finally, in January 2015, the sequence of 60 000 
anonymous exomes were released by the Exac database (http://exac.broadinstitute.org/) 
revealing the existence of 68 THRA mutations, so the incidence seems to be around 1:10.000! 
Unfortunately, the Exac database does not give access to personal data. 
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1.6 THYROID HORMONE ACTION IN THE BRAIN 
The behavior and locomotor phenotype of TRα1+m mice is accompanied by impaired 
development of GABAergic interneurons in the brain (Venero et al., 2005; Gilbert et al., 
2007; Wallis et al., 2008). In the following my focus will be on the development of the brain 
and in particular on GABAergic cells and the influence of TH in response to the neurological 
phenotype of TRα1+m mice. 
 
1.6.1 Brain development  
Before closure, the anterior end of the neuronal tube forms the three primary brain vesicles: 
prosencephalon, mesencephalon (later midbrain) and rhombencephalon (later hindbrain). The 
prosencephalon consists of the diencephalon (later thalamus) and the telencephalon. The 
latter is responsible for higher brain function and gives rise to the neocortex, hippocampus, 
basal ganglia and olfactory bulb (Stiles & Jernigan, 2010). The neocortex is the largest and 
most crucial part of the telencephalon. It is involved in cognition, sensory perception and 
locomotor processes. Distinct well-organized areas of the neocortex are responsible for 
certain tasks, and differ by neuronal constellation, connectivity and density, and are generally 
divided in six layers (lamina). Neurons of the distinct layers target different areas of the brain, 
e.g. pyramidal cells in layer II and III project to other areas of the neocortex, whereas 
pyramidal cells of layer IV and V send their axons outside the cortical layers (e.g. thalamus). 
Pyramidal cells belong together with spiny stellate cells to the group of glutamatergic 
excitatory neurons which account for 80% of all neocortical neurons and exist in fine balance 
with the remaining 20% of inhibitory interneurons in the neocortex (Sultan et al., 2013). 
 
1.6.2 GABAergic interneurons  
Interneurons using the neurotransmitter gamma aminobutyric-acid (GABA) control the 
information distribution in the cortex; they time firing of excitatory pyramidal cell, 
synchronize network activity, fine tune neuronal firing to oscillation and keep a well-adjusted 
excitatory and inhibitory balance. Defects in GABA transmission are involved in 
neurological and psychiatric diseases, such as epilepsy, anxiety or autism (Cobos et al., 2006; 
Rudy et al., 2011). The different tasks require highly specialized cells. I 
Generally, GABAergic cells are spiny and partially spiny non-pyramidal cells that express the 
glutamic acid decarboxylase (GAD) required for GABA synthesis from glutamate. They are 
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connected with excitatory and inhibitory cells in their vicinity and can extend horizontal or 
vertical axons, with their cell body mostly in layer II-IV in the cortex. Their inhibitory 
synapses target soma, dendrites, axons or presynaptic boutons on particular neurons to 
establish inhibitory circuits (Fig. 5). Consistently, interneurons are a heterogenous group of 
cells that can be distinguished by their morphology, electrophysiology and neurochemical 
properties (Brandao & Romcy-Pereira, 2015). One possibility is to subdivide interneurons 
neurochemically into three major groups. Members of those groups express either the 
calcium binding protein parvalbumin (PV), the neuropeptide somatostatin (STT) or the 
ionotropic serotonin receptor (5Ht3aR). Each group consists of several types of interneurons 
with a different morphological and electrophysiological profile but the same origin. PV 
identifies fast spiking basket and chandelier cells and accounts for 40% of GABAergic cells 
in the cortex. 30% of GABAergic interneurons express SST, which serves as markers for 
burst-spiking Martinotti cells and cells that specifically target layer IV, whereas 5Ht3aR 
stains the remaining 30% of GABAergic interneurons including vasointestinal protein (VIP) 
non/expressing cells (Lee et al., 2010; Rudy et al., 2011). It is of note that other calcium 
binding proteins such as calretinin or calbindin are often used to distinguish interneurons, but 
they overlap with PV, SST or VIP expression.   
 
Figure 5: Schematically representation of interneuron distribution and connectivity in the laminar 
structure of the cerebral cortex. Modified from (Marin, 2012). 
 
1.6.2.1 Origin and migration of interneurons 
Interneurons subgroups originate of distinct areas of the developing brain. 5Ht3aR cells, CR 
and/or VIP expressing cells originate in the caudal ganglionic areas. In contrast, PV+ and 
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SST+ cells arise from subpallial progenitors in the medial ganglionic eminence (MGE). 
Specifically, PV+ interneurons are born in the ventral part of MGE (vMGE), whereas the 
dorsal MGE (dMGE) generates SST+ cells (Cobos et al., 2006; Flames et al., 2007). After 
proliferation in the ventricular zone, MGE derived interneurons migrate tangentially to their 
destination in the cortex by generating a leading process with multiple branches to detect 
chemical cues on their journey to their final destination. Once the cell decided for a moving 
direction, the leading process is stabilized, the organelles form a presomal swelling into the 
process followed by a nucleus translocation towards the swelling (Guo & Anton, 2014). 
At E11.5 an early stream of interneurons migrate from the MGE on a superficial path through 
the marginal zone (MZ), circumventing the striatum to form the preplate at the surface of the 
cortex. At E12.5- E.14.5 a second stream of interneurons migrate through a deep route along 
the intermediate zone (IZ) and the superficial MZ to avoid the striatal mantel and cortical 
plate (Fig. 6) (Marin & Rubenstein, 2001). In late corticogenesis cells mainly migrate through 
the IZ/SVZ to invade the cortical plate; however, migration streams can also be observed in 
the MZ and subplate. The latter arises from the preplate. Once interneurons reach the cortical 
plate they switch to radial migration to find their destination (Sultan et al., 2013). Early born 
MGE cells are located in the deep layers of the cortex, whereas younger cells migrate past the 
older cell and invade upper layers of the cortex.  
 
Figure 6: Migration streams in the developing forebrain: 1 Exit of proliferation site, 2-4 selection of 
migration stream and orientation, 5 identification of final destination, 6 termination of migration. 
CGE: caudal ganglionic eminence, CP: cortical plate, LGE: lateral ganglionic eminence, MGE: 
medial ganglionic eminence, MZ: marginal zone, IZ: intermediate zone, POa: preoptic area, SVZ: 
subventricular zone, VZ: ventricular zone. Modified from (Guo & Anton, 2014). 
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Migration onset is initiated by the chemorepellent ephrin-5, which is expressed in the 
ventricular zone (VZ) of the ganglionic eminence (GE) and signals through its receptor 
EphA4 expressed in newborn cells, consequently downregulation of EphA4 leads to an 
infiltration of the VZ (Zimmer et al., 2008). Once released from the VZ mitogenic factors 
hepatocyte growth factor (HGF) and the glial cell derived neurotrophic factor (GDNF) were 
found to be required for migration, as a lack of these genes lead to migration deficits (Powell 
et al., 2001; Pozas & Ibanez, 2005). Interestingly, MGE derived cells express the 
neurotrophin receptor TrkB that binds to brain derived neurotrophic factor (BDNF) and 
neurotrophin-4 (NT-4). Disruption of BDNF signaling reduced the number of interneurons, 
indicating at least a modulating function of neurotrophins on interneuron motility (Polleux et 
al., 2002; Guo & Anton, 2014) as it was later shown that neurotrophoic factors are 
dispensable or may only affect specific interneuron subpopulations (Marin, 2013).  
During migration chemoattractant and chemorepellent factors provide interneurons with 
direction cues. MGE derived interneurons avoid entering the preoptic area (POa) and 
striatum, due to region specific expression of chemorepellents. Ephrin B-3 expressed in the 
POa interacts with its EphA4 receptor in MGE cells, repelling them and keeping them on the 
right path to the cortex. This is accompanied by secretion of the chemorepulsive factors class 
III semaphorins (Sema3A, Sema3F) in the striatum, with its receptor neuropilin expressed in 
MGE cells (Rudolph et al., 2010; Hernandez-Miranda et al., 2011). Consistently, cells 
targeting the striatum do not express those receptors. Additionally, the transcription factor 
Nkx2.1 is downregulated to enhance the repellent function of Sema3A/ Sema3F, consistently, 
high levels of Nkx2.1 reduce the repellent function of Sem3a, and cells infiltrate the striatum 
(Nobrega-Pereira et al., 2008; Guo & Anton, 2014). 
Neuregulin-1 acts together with its receptor ErbB4 as the only identified chemoattractant, 
which attracts MGE derived cells to the neocortex (Flames et al., 2004). Moreover, migrating 
interneurons become responsive for neurotransmitters, with increased sensitivity for GABA 
and glutamate when leaving the subpallium to the neocortex, with a dopamine 1 receptor 
activating migration and with glycine controlling nucleokinesis (Guo & Anton, 2014). 
Interstingly, GABA and glutamate depolarize cells in the post-mitotic cortex through their 
receptors, leading to a Ca2+ transient which keeps cells migrating (Brandao & Romcy-Pereira, 
2015).  Once in the neocortex the chemoattractant CXCL12 - expressed in the MZ and SVZ - 
keeps the MGE interneurons in the migration stream, but only if they express both CXCL12 
receptors (CXCR4/CXCR7). The responsiveness to CXCL12 is downregulated when 
interneurons perform the final step of migration – a switch from tangential to radial 
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migration. As the radial migration is perturbed in the absence of the adhesion protein 
Connexin 43, it is believed that radial glia interneuron interaction is required additionally for 
the transition (Guo & Anton, 2014). The final placement may depend on interaction with 
pyramidal cells and neuonal activity. With the expression of the potassium chloride channel 
KCC2, only few hours after the cells reach the cortex, GABA becomes hyperpolarizing 
which in turn inhibits the motility of cells (Brandao & Romcy-Pereira, 2015). During 
maturation and migration interneurons express different combinations of transcription factors 
believed to be involved in interneuron specification.  
 
1.6.2.2 Interneuron specification  
Two mechanisms are important for cell fate specification, the intrinsic molecular cues, which 
are the expression of distinct sets of transcription factors in distinct groups of interneuron 
precursors, responsible for the early commitment to a specific neuronal fate, and the extrinsic 
cues provoked by the cell environment such as neural activity (Cobos et al., 2006). The origin 
of SST+ cells, the dMGE, is enriched in Nkx6.2 and Gli, whereas the major source of PV+ 
cells the vMGE showed an enrichment in Dlx5/6 and Lhx6. Furthermore, in the early MGE, 
Nkx2.1 promotes specification of SST+ and PV+ cells. During that stage sonic hedgehog 
(Shh) signaling is stronger in the dMGE than in the vMGE favoring SST+ cell development 
(Fogarty et al., 2007). Consistently, high levels of Shh signaling were found to support SST 
fate acquisition (Xu et al., 2010). Loss of Nkx2.1 on the other hand leads to a fate shift from 
MGE cells to LGE cells, reducing the number of cortical interneurons by more than 50% 
(Sussel et al., 1999).  
As a direct target of Nkx2.1, Lhx6 expression is induced and coordinates intracellular 
processes required for the specification of both cell types. Deletion of Lhx6 leads to a loss of 
almost all PV+ and SST+ cells in the cortex besides a small number of scattered cells in the 
deep layers, which were later identified as potentially POa derived PV+ cells (Liodis et al., 
2007; Brandao & Romcy-Pereira, 2015). Lhx6 expression is maintained in mature cells, and 
is exclusively found in PV+ and SST+ cells (Fogarty et al., 2007; Liodis et al., 2007). Sox 6 
(and Satb1) acts downstream of Lhx6 and is required to generate the accurate number of PV+ 
and SST+ cells and involved in their placement and maturation (Batista-Brito et al., 2009). 
Moreover, the Dlx homeobox genes are widely expressed in postmitotic and mature cells. 
Dlx5 or Dlx5/6 knockout mice exhibit specific loss of PV+ cells in the cortex, whereas the 
deletion of Dlx1 reduces SST but not PV expressing cells.  
  17 
Most characteristics of the interneuron subtypes are only present in a later postnatal brain. 
Additionally, immature PV and SST cells express similar transcription factors, which hinder 
the identification and distinction of immature PV and SST cells (Fig. 7). They only become 
neurochemically distinguishable when the cells undergo the final step of differentiation and 
start to express PV around P7 or SST from P0 on (Sanchez et al., 1992; Lee et al., 1998; Hof 
et al., 1999). Given the similar origin, migration path and expression of transcription factors it 
is astonishing that only PV+ cells are affected in the TRα1+m mice. 
 
          
Figure 7: Expression of transcription factors through out maturation of MGE derived SST+ and PV+ 
cells. Note the identical set of transcription factors expressed by both subpopulations. VZ: ventricular 
zone, SVZ: subventricular zone, CP: cortical plate. Modified from (Cauli et al., 2014). 
 
1.6.2.3 Neuronal activity 
The maturation of GABAergic cells is modulated by the activity of their postsynaptic partners 
and by the expression of activity dependent growth factors (Patz et al., 2004). Consequently 
dark reared animals exert reduces PV expression and reduced GABAergic inhibition in the 
visual cortex, with the latter improving drastically by visual input (Morales et al., 2002; 
Tropea et al., 2006).  
In the cortex neuronal activity depends on synaptic transmission, neuronal connectivity and 
proper pH levels. Excitation leads to the release of glutamate and dopamine from the 
presynaptic cell. These neurotransmitters bind in case of inhibition to its receptors on 
inhibitory interneurons, which in turn release GABA. GABA than binds to its postsynaptic 
receptors where it initiates hyperpolarization by opening Cl- and K+ channels, leading to a 
negatively charged postsynaptic cell (hyperpolarization). The change in the electrochemical 
gradient is accompanied by an extracellular alkaline shift caused by an net influx of CO2 and 
HCO3- efflux through the GABAA receptor gated Cl- channel leading to postsynaptic acidosis 
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(Kaila & Voipio, 1987; Chesler, 2003; Sinning & Hubner, 2013). Interestingly, breathing of 
5% CO2 inhibits seizures, most likely due to an enhanced inhibition caused by increased 
intracellular acidosis (Pavlov et al., 2013). Like inhibition, excitation leads to an extracellular 
alkaline shift which is HCO3- independent, but arises due to an extracellular H+ sink (Chesler 
& Kaila, 1992). This is accompanied by a Na2+ influx that depolarizes the postsynaptic cell.  
The alkaline shift in both cases is buffered by carbonic anhydrases, which hydrate CO2 and 
dehydrate HCO3-  (CO2 + H20       HCO3- + H+). The membrane bound carbonic anhydrase 4 
and 9 (Car4, Car9) buffer the extracellular alkaline shifts. Knockout studies demonstrated the 
ability of both to substitute for each other, whereas a lack of both isoform led to a stronger 
extracellular alkalization (Huang et al., 1995; Shah et al., 2005). Additionally, Cars also 
influences synaptic transmission by buffering H+, which was shown to modulate the 
glutamate NMDA receptor activity; consequently a lack of Cars increases intracellular H+ 
and reduced NMDA receptor response (Taira et al., 1993).  
 
1.7 TR DISTRIBUTION IN THE BRAIN 
The importance of TRs in brain development was described decades ago. Unfortunately, a 
lack of reliable antibodies against the TR moiety made it impossible to dissect the cell 
specific expression of TRs in the brain. Alternative methods were used to create a rather 
vague picture of spatial and temporal TR expression.  Briefly, TRα1 is the predominant TR 
isoform in the brain where it is ubiquitously expressed and accounts 70-80% of total T3 
binding (Schwartz et al., 1992; Ercan-Fang et al., 1996). In particular TRα1 was present in 
areas such as cortex, hippocampus, cerebellum and amygdala in postnatal to adult rats, with a 
peak in the first three weeks of life and an expression onset at E5 in chicken and E14 in rat  
(Forrest et al, 1996a; Mellstrom et al, 1991).  In contrast, TRβ expression was restricted to 
selected rather mature neuronal subpopulations. Consistently only low levels were detected 
prenatally but increased during postnatal development, with expression in hippocampal 
granule and pyramidal cells, cerebellar Purkinje cells and paraventricular hypothalamic 
neurons (Horn & Heuer, 2010).  
 
1.7.1 Effects of TRα1 alteration on brain structure and function  
In the following years the role of TRα1 in brain development and function was studied in 
several brain regions. The focus was on the cerebellum with an import role in motor control, 
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the hippocampus involved in memory consolidation and space as well as the motor cortex, 
which plans, controls and executes voluntary movements. 
 
1.7.1.1 Cortex 
The neocortex regulates higher function such as motor commands, conscious thoughts and 
language. In hypothyroidism the number of PV+ terminals in the neocortex is strongly 
reduced (Berbel et al., 1996). Wallis et al. demonstrated that the dominant negative mutation 
in TRα1 (TRα1+m) affects the development of GABAergic interneurons. In particular, the 
number of PV expressing interneurons in the motor cortex of TRα1+m mice were 
significantly reduced in P14 mice but normalized in adulthood, whereas calretinin expressing 
cells were increased in juvenile and adult mice. Consistently, staining for GAD67, an enzyme 
expressed in GABAergic cells, revealed no alteration in cell number. However, PV+ cell 
development was rescued by high doses of TH from around birth on, whereas high TH levels 
during embryogenesis did not improve PV+ cell development.  
Behavior test revealed locomotor disabilities and poor performance in the hanging wire test, 
but normal muscle development. These defects improved by both embryonic (E10.5 – E13.5) 
and postnatal TH treatment (Wallis et al., 2008).  
 
1.7.1.2 Hippocampus 
The functionality of the rodent hippocampus can be tested by several behavior tests targeting 
memory formation. Contextual fear experiments engage the hippocampus and amygdala, 
whereas the cued fear test depends on the integrity of the amygdala and lastly, the novel 
object recognition test, which measures hippocampus dependent visual memory (Guadano-
Ferraz et al., 2003). 
As the deletion of TRα1 lead to less exploratory behavior in open field experiments and a 
higher freezing response in contextual fear experiments - but not in the cued fear test - it was 
suggested that TRα1 plays a crucial in hippocampal function. On a neuronal level, fewer 
GABAergic terminals on pyramidal cells in the CA1 region of the hippocampus accompany 
the described behavior phenotype. These findings indicate an involvement of TRα1 in the 
development of inhibitory circuits in the hippocampus and, hence, a modulating function on 
creating emotions and hippocampal memory (Guadano-Ferraz et al., 2003). In 2005, Venero 
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and colleagues used the TRα1+m mouse strain to understand the role of the aporeceptor in 
brain development and function. They discovered anxiety and reduced hippocampus-
dependent visual recognition memory in adult mutant mice, which they connected to a 
reduced number of PV+ perisomatic terminals in the CA1 region of the hippocampus. All 
defects were ameliorated with TH treatment in adulthood (Venero et al., 2005). Additionally, 
TRα1+m mice showed reduced seizure susceptibility to chemically induced seizures, 
accompanied by hyperpolarization and reduced cell activation upon seizure induction. These 
findings were reversed by TH treatment during both embryonic and postnatal development. 
Histological analysis of brain sections revealed increased numbers of inhibitory calretinin 
cells in the hippocampal hilus, suggesting a stronger inhibition or reduced excitability of the 
hilus leading to reduced seizure susceptibility (Hadjab-Lallemend et al., 2010).  
 
1.7.1.3 Cerebellum and hypothalamus  
Congenital hypothyroidism is associated with cerebellar misdevelopment and locomotor 
disabilities. Hypothyroidism in wildtype but not in TRα1 knockout mice caused a delayed 
postnatal migration of external granule cells to the internal granular layer of the cerebellum 
and arrested development of Purkinje cells, suggesting an involvement of the apo-receptor in 
inhibiting cell migration and partly Purkinje cell maturation (Morte et al., 2002). This 
hypothesis was confirmed by using TRα1+m mice, which showed a delayed migration of 
external granule cells and a minor delay in Purkinje cell maturation accompanied by 
locomotor impairment on the Rotarod. Thyroid hormone treatment in adulthood improved the 
neurological phenotype, whereas postnatal treatment was necessary to ameliorate the 
locomotor alterations (Venero et al., 2005). Additional immunohistological studies identified 
an overall delay of PV, calbindin and calretinin expressing interneurons in TRα1+m, which 
normalized at around P9 (Wallis et al., 2008). To elucidate whether T3 acts directly or 
indirectly on cell maturation a mouse model with a floxed mutant TRα1 was used to express 
the dominant negative receptor selectively in different cell types (Fauquier et al., 2014). This 
study identified a cell autonomous affect of TRα1 on Bergman glia and Purkinje cell 
development, which in turn modulates granule cell migration. The expression of a dominant 
negative TRα1 in Purkinje cells, Bergman glia and interneurons increased the amount of 
immature GABAergic cells, and reduced the number of mature PV+ cells and GABAergic 
synapses in juvenile mice. Further studies revealed the influence of Purkinje cells on 
interneurons during early postnatal development whereas Bergman glia affected interneuron 
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maturation in a later stage. However, as no interneuron specific mouse line was studied, a cell 
autonomous affect of TRα1 on interneuron development could not be excluded (Fauquier et 
al., 2014).  
Additionally, in the hypothalamus a reduced expression of PV+ cells was identified in 
TRα1+m mice, which could not be rescued by TH treatment in adulthood or postnatally. The 
additional deletion of TRβ decreased their number even further, suggesting the importance of 
a proper TRα and TRβ signaling during embryogenesis (Mittag et al., 2013). 
Taken together, all examined brain regions of TRα1+m mice revealed disturbed PV+ cell 
development, with the majority being rescued by TH treatment.  
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2 AIMS 
The overall purpose of my PhD thesis was to identify the role of TRα1 in interneuron 
development by determining TRα1 expression in the tissue, identifying novel target genes 
and unraveling a possible mechanism by which TRα1 affects parvalbumin+ cell 
development. The specific aims of my thesis were to:  
 
1. identify the spatial and temporal expression of TRα1 in the developing and adult 
brain by analyzing a mouse strain expressing a chimeric TRα1-GFP protein;  
2. establish a method to reliably detect TRα1 target genes using the TRα1-GFP mouse 
strain; 
3. characterize Carbonic anhydrase 4 (Car4) as novel TRα1 target gene in the brain; and  
4. unravel the molecular mechanism underlying the delayed appearance of parvalbumin 
expressing interneurons in TRα1+m mice.  
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3 RESULTS 
3.1 TRα1 EXPRESSION IN THE DEVELOPING AND MATURE BRAIN - PAPER I 
Several studies have described the importance of proper TRα1 activity in the brain and 
identified cell types depending on TRα1. Wallis et al. describe a delayed appearance of 
cortical GABAergic PV+ cells in mice with a dominant negative TRα1 (Wallis et al., 2008); 
a similar delay was described in the cerebellum (Venero et al., 2005; Fauquier et al., 2014). 
However, the lack of reliable TRα1 antibodies prevented the proper identification of TRα1 
expressing cell types and hence, hampered the understanding of molecular mechanisms 
causing the interneuron phenotype.  
 
Generation of mice and phenotype analysis 
In order to determine the temporal and spatial expression of TRα1 in the brain, we generated 
a transgenic mouse line carrying a GFP sequence in the reading frame of Thra. The sequence 
was inserted in frame 3’ to exon 9 of Thra, resulting in the expression of a chimeric TRα1-
GFP protein from the endogenous Thra locus. Since the expression is regulated by the 
endogenous promotor, the chimeric protein is generally expressed where and when TRα1 is 
normally activated. The functionality of the chimeric protein was first tested in transfection 
assays, where it showed a slightly reduced ability to suppress target gene expression. This 
was later confirmed in heart tissue of homozygote TRα1-GFP (TRα1gfp/gfp) mice that 
revealed increased expression of the negatively regulated target gene MyHCβ (cardiac 
muscle myosin heavy chain beta), whereas the positively regulated MyHCα (Dillmann, 
1990) was unaltered. These findings indicated a somewhat reduced suppression of 
transcription in the homozygote mice but normal gene activation.  
We further analyzed the Thra transcripts after GFP introduction into the mouse genome. 
Northern blots revealed the expected increase of Thra transcript size, but it also showed a 
reduction of TRα2 expression in the TRα1+/gfp mice and a loss of the TRα2 transcript in the 
homozygote mice, accompanied by an increased expression of the TRα1-GFP. These results 
were confirmed with qPCRs. As the knock-in led to a decreased transcriptional suppression 
and abolished TRα2 levels we tested physiological and behavioral parameters. We found 
small variations in weight development of heterozygote male mice, which normalized in 
adulthood.  Eye opening as parameter for development was unaltered. Heart and brain size 
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were unchanged whereas the liver size of TRα1gfp/gfp mice was decreased. To exclude a 
functional deficit in the liver caused by the TRα1-GFP we examined liver deiodinase 1, 
which is regulated by TH. No difference was observed, indicating no TH mediated functional 
deficit in the liver.  
Since our study focused on TRα1 in the brain we examined the T3 regulated genes RC3 and 
hairless (Thompson & Bottcher, 1997; Martinez de Arrieta et al., 1999) in the developing 
brain and could not find any alteration. Also the expression of the corepressors Ncor and 
Alien were unchanged in the juvenile brain. Adult mice behavior was than tested in SHIRPA 
where no alteration was observed. 
In summary, no differences could be detected in the brains of TRα1-GFP mice compared to 
wildtypes.  TH target gene expression was not effected and the behavior of TRα1-GFP mice 
did not show any abnormalities. Since we observed a decreased repression of genes in the 
homozygotes we used heterozygote mice for TRα1 expression studies.  
 
TRα1 expression in the mature brain 
In order to characterize TRα1 expression in the brain we used anti-GFP antibodies to detect 
TRα1-GFP in coronal brain sections. Immunohistochemistry revealed exclusively nuclear 
TRα1 expression in the neocortex, striatum, hippocampus, hypothalamus and cerebellum, 
supporting previous findings (Mellstrom et al., 1991; Bradley et al., 1992). It was not 
detected in white matter, indicating a major expression in neurons.Colocalization for TRα1-
GFP and the neuronal marker NeuN confirmed expression of TRα1-GFP in virtual all 
neurons of the adult brain, with the exception of Purkinje cells in the cerebellum (see below). 
Additionally, TRα1-GFP colocalized with parvalbumin and calretinin expressing 
interneurons, cell populations diversely affected in mice harboring a mutation in TRα1 
(Wallis et al., 2008). In glial cells TRα1 was detected in tanycytes lining the third ventricle of 
the hypothalamus, which constitute an important barrier between cerebrospinal fluid and 
hypothalamus, and in mature oligodendrocytes of the hypothalamus. Earlier observations 
proposed a TH dependent maturation of oligodendrocytes through a sequential expression of 
TRβ and TRα (Billon et al., 2001; Billon et al., 2002), which could be supported by our 
finding.  
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TRα1 in the cerebellum 
In the cerebellum TRα1 was absent in mature Purkinje cells, but showed transient expression 
in immature Purkinje cells at P7, which is in line with previous observations (Heuer & 
Mason, 2003). Adjacent to Purkinje cells we identified parvalbumin expressing stellate/ 
basket cells that were positive for TRα1.  
The influence of TH on granule cell proliferation and migration was described previously. 
The apo-TRα1 was associated with a delayed migration onset of the granule cells of the 
external granular layer (Morte et al., 2002; Venero et al., 2005). In our study, TRα1 was 
absent in proliferating cells of the external granular layer but appeared in migrating cells in 
the molecular layer. Moreover, GFAP (Glial fibrillary acidic protein) positive glial cells of 
the granular layer expressed TRα1.  
 
TRα1 in the developing cortex 
We further investigated the expression onset of TRα1 during neuronal development. At E9.5 
TRα1 was not detected in the developing brain but appeared at E13.5 in the cortical plate and 
marginal zone, whereas proliferation sites were negative for TRα1 expression. TRα1 cells 
were identified with β-tubIII as immature postmitotic neurons. This is in line with our 
observations in the cerebellum, where TRα1 was found in migrating cells of the molecular 
layer, but was absent in the proliferation site (external granular layer). TRα1 was detected in 
the cortical plate throughout development, with a stronger expression in the deeper layer 
where cells have already matured. After finalized cortical lamination, TRα1 showed even 
expression throughout the layers.  
Taken together, the TRα1-GFP mouse enabled us to detect TRα1 protein expression in the 
brain for the first time: from E13.5 TRα1 is expressed in postmitotic cells and continues to be 
expressed in virtually all neurons of the adult brain except for Purkinje cells, indicating a role 
in cell maturation and maintenance. Moreover, TRα1 is expressed in tanycytes and mature 
oligodentrocytes of the hypothalamus. 
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3.2 IDENTIFICATION OF TRα1 TARGET GENES - PAPER II 
The TRα1-GFP mouse strain was a valuable tool to detect TRα1 expression on a cell level in 
the brain. We hypothesized that this mouse line could also be used to identify TRα1 target 
genes with chromatin immunoprecipitation (ChiP), as our mouse line enabled us to 
circumvent the need for a TRα1 antibody by using GFP antibodies. We then successfully 
establish a protocol to use the TRα1-GFP mouse strain in ChIP assays in order to identify 
TRα1 target genes.   
 
ChIP assay and method validation 
Protein-DNA interaction can be detected with chromatin immunoprecipitation. Briefly, tissue 
is incubated in PFA to cross-link DNA and attached protein, followed by formaldehyde 
quenching and homogenization of tissue. Cells are lysed, sonicated to break DNA in smaller 
pieces (500-1000kb) and the ChIP DNA is incubated in an antibody solution. The DNA-
protein-antibody complex is then immunoprecipitated (pull-down) with protein G-coated 
magnetic beads. After heat induced reverse crosslinking and protein digestion, the enrichment 
of the specific DNA sequence in ChIP DNA compared to untreated input DNA is verified 
with qPCR and normalized to background noise in wt ChIP and the corresponding input 
DNA.  
ChIP assays were performed on TRα1gfp/gfp brain and heart tissue using a GFP antibody and 
wildtype chromatin as control. We investigated previously described TREs in hairless 
(Thompson & Bottcher, 1997) and RC3 (Martinez de Arrieta et al., 1999) to validate our 
system and included genomic DNA without TREs as negative control...We observed TRα1-
GFP binding to RC3 and hairless TREs whereas the negative control did not produce any 
pull-down.  
Next we investigated the heart as an additional TRα1 target organ. We identified TREs in the 
promotor regions of the TH regulated genes Sema3a (Semaphorin 3a), HCN2 and HCN4 
(hyperpolarization-activated cyclic nucleotide-gated ion channel 2 and 4) (Mittag et al., 
2010a), which bound to TRα1 in the assay. Electrophoretic mobility shift assay (EMSA) 
confirmed the binding ability of the previous described and the majority of novel identified 
TREs as heterodimer with RXR to TRα1 and TH. We further analyzed the functionality of 
TREs in luciferase assays after cotransfection of cells with TRα1 and a TRE containing 
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plasmid (Hofmann et al., 2009). All TREs increased luciferase expression upon TH 
treatment, independent of their localization in the promotor.   
 
Identification of novel TH target genes 
We aimed to identify new target genes by cloning the sheared chromatin precipitate. 
Sequencing of random clones revealed RNF166 (ring finger protein 166) as possible 
candidate. A putative TRE was identified in the 3’UTR (untranslated region) downstream of 
the promotor region and ChIP assay revealed binding of TRα1 to the TRE. EMSA confirmed 
the binding ability, as the TRE bound monomeric or as heterodimer with RXR to TR. The 
TRE was than cloned into a promotor vector for luciferase assay where it induced luciferase 
expression upon TH treatment. Lastly, qPCR revealed a reduced expression of RNF166 
mRNA upon TH treatment.  
 
Protein-DNA interaction in hypo and hyperthyroid mice 
It is hypothesized that TRs are bound to DNA in absence and presence of ligands. We 
addressed this question and treated animals either with an anti-thyroid drug (methiamazole) 
to reduce their TH levels to a hypothyroid state or injected TH to increase TH levels. 
Subsequent ChIP assay revealed no effect of ligand availability on TRα1-DNA binding when 
compared to the euthyroid mice, supporting the hypothesis of a steady binding of TRα1 to 
DNA. 
Taken together animal models expressing a GFP tagged transcription factor are an excellent 
tool to analyze DNA-protein interactions in vivo and can be used to identify new target genes.  
 
3.3 CAR4: A NOVEL TRα1 TARGET GENE - PAPER III 
Equipped with the established ChIP assay we were eager to identify additional TRα1 target 
genes. Carbonic anhydrases 4 (Car4) regulates together with other Car isoforms the activity 
dependent pH shift in GABAergic cells and is involved in synaptic transmission (Urbanics et 
al., 1978; Tong et al., 2000). Moreover, Car4 is expressed in the kidney and lung, which 
functions are closely related to proper TH signaling. These made Car4 an interesting 
candidate for further investigation.  
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Car4 expression in brain, kidney and lung  
In situ hybridization studies for Car4 showed a reduced expression in the cortex and thalamus 
of the TRα1+m mice, which slightly increased upon TH treatment, indicating an early 
established defect on Car4 expression. Similar to what was found in the brain, Car4 mRNA 
expression was also reduced in the lung of TRα1+m mice and did not recover upon TH 
treatment. The TH treatment efficiency was verified by additional qPCRs for the TH 
regulated genes surfactant protein A and serpina 3G, which showed the expected regulation 
(Ramadurai et al., 1998; Barca-Mayo et al., 2011). Since Car4 is involved in the regulation of 
pulmonary CO2 (Fleming et al., 1993), we measured respiratory rate and oxygen saturation as 
readout for in vivo lung function. None of them were affected in the mutant mice; however, 
TH treatment increased the respiratory rate in both genotypes.  Analysis of mRNA levels of 
other Cars did not show a difference between genotypes, but TH treatment led to increased 
expression of Car2 and Car14 in the mutant mice. 
In the kidney Car4 is involved in renal regulation of pH levels and bicarbonate reabsorption 
(Purkerson & Schwartz, 2007). Here, its expression was not affected by the apo-TRα1 in the 
mutant mice, but was down-regulated on the RNA and protein levels when treated with TH in 
both genotypes, indicating a TH dependent repressive regulation of Car4 transcription 
probably mediated by TRβ. Deiodinase1 served as treatment control and showed the 
expected increase induced by TH treatment.  However, the reduced Car4 levels did not 
influence pH levels in urine, which prompted us to investigate other Cars. Indeed, Car7 and 
Car15 were induced upon TH treatment, probably to compensate for the suppressed Car4 or 
as result of transcriptional activation by TH. 
 
Car4 a new target gene for TRα1 
We identified four putative TREs in the promotor region of Car4. Three of them showed 
enriched TRα1 binding in the ChIP assay and one of them demonstrated the expected 
transcriptional repression upon TH treatment in luciferase assay. In the same setting a 
plasmid containing the specific TRE with mutated bases to alter TRα1 binding, failed to 
regulate luciferase activity, whereas a plasmid upgraded to contain a perfect TRE upregulated 
luciferase activity. With this experiment, we identified Car4 as a novel negatively regulated 
TH target gene by a TRE in position -2385 relative to the translation start site. 
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Taken together, we identified tissue specific Car4 regulation by TH. In tissues predominately 
expressing TRα1 (brain and lung), we discovered a permanent repression of Car4, whereas 
the kidney predominately expressing TRβ showed acute TH regulation leading to suppressed 
Car4 expression upon TH treatment. The latter is of great interest, as Car4 can be used as an 
additional novel marker for TH status in the kidney.  
 
3.4 TRα1 ACTION IN INTERNEURON DEVELOPMENT - PAPER IV 
A previous publication from our lab described a delayed appearance of a GABAergic cell 
subpopulation in the cortex of TRα1+m mice. In particular, the number of parvalbumin (PV) 
expressing interneurons was decreased at P14 but their number normalized in adulthood 
(Wallis et al., 2008). Somatostatin (SST) cells, which undergo a similar migration and 
developmental path and express the same transcription factor as PV+ cells (Marin & 
Rubenstein, 2003), were not affected by the dominant negative receptor. In paper I we 
showed that TRα1 is expressed in PV+ interneurons as well as in immature neurons. In this 
project, we investigated whether the mutation affects migration, survival or differentiation of 
PV interneurons and used ChIP assays to characterize possible target genes. The animals 
were studies at P7, when immature PV cells start to undergo their final step of maturation and 
at P14 when the delayed appearance of PV+ cells becomes apparent.  
 
Identification of immature PV cells in the cortex 
First, we analyzed mRNA levels with qPCR of markers expressed in PV+ and SST+ cells. 
BMPR1a and 1b showed no alteration between the genotypes at both time points. The same 
result was found for NMDA receptor 1 as well as for ERbB4, which expression is restricted 
to 85% of PV+ cells and 15% of SST+ cells. We next examined the expression of the PV+ 
cell exclusive marker Kv3.1b, which revealed no difference between the genotypes. From 
that we concluded that the immature PV+ cells reach the cortex but fail to undergo the final 
step of differentiation, which is associated with the onset of PV expression.  
 
Analysis of transcription factors 
In a next step we investigated the transcription factors Dlx5 and Lhx6, both needed for PV+ 
cell differentiation. QPCR revealed upregulation of both genes in the mutant mice at P7, 
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which normalized at P14. Subsequent ISH for the PV and SST specific transcription factor 
Lhx6 at P7 and P14 showed no alteration between the genotypes and quantification of Lhx6 
expressing cells revealed a similar number of Lhx6 positive cells in the cortex of both 
genotypes. ISH for Dlx5 at P7 confirmed the increases expression. Lastly, we determined 
PGC1α expression, a modulator for PV expression, which did not show alteration between 
the genotypes.  
These results supported the idea that the immature PV cells reach the cortex but fail to 
differentiate. Additionally, the increased mRNA levels of Dlx5 and Lhx6 at P7 might indicate 
a compensatory effect for the delayed differentiation.  
 
Neuronal activity  
The expression of PV is modulated by neuronal activation (Patz et al., 2004). Neuronal 
activity depends among others on the availability of neurotransmitters. Consequently we 
analyzed the protein levels of the inhibitory neurotransmitter GABA and the excitatory 
neurotransmitters dopamine and glutamate. ELISAs revealed no difference between the 
genotypes. In the following we wanted to increase the cortical activity by injecting the 
convulsant drug PTZ (pentylenetetrazol). PTZ binds to the GABAA receptor and initiates 
depolarization by increasing calcium and sodium influx and hence increases excitation. This 
in turn leads to release of glutamate, which acts on inhibitory interneurons (Huang et al., 
2001). Immunohistochemistry for PV revealed a loss of PV+ cells in the mutant mice 
compared to untreated mutants, whereas wt mice were unaffected. From that we concluded 
that the excitatory/ inhibitory system is not fully developed and that the increased excitation 
might have induced cell death.  
 
Dominant negative TRα1 affects the expression of neurotrophin-3  
Neurotrophins are crucial players in interneuron development and especially BDNF was 
shown to regulate PV+ cell differentiation in an activity dependent manner (Patz et al., 2004). 
We analyzed mRNA levels of neurotrophin receptors TrkB, TrkC and p75 and their ligands 
BFND, NGF, NT-3 and NT-4/5. TrkC, p75, BDNF, NGF and NT-4/5 were unaffected in the 
mutants at both time points, whereas TrkB expression was significantly elevated at P14 in the 
mutant cortex, whereas NT-3 levels were significantly reduced in this animals. Western blot 
analysis revealed reduced NT-3 protein levels also at P7. We then investigated whether the 
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NT-3 genomic sequence contained TRE sequences. We identified two putative TREs in the 
promotor region and subsequent ChIP assay revealed TRα1 binding to a TRE located -606 
relative to the translation start site. Next we analyzed the expression of downstream genes of 
NT-3 and identified a reduced phosphorylation of AKT (phosphoAkt) and a slightly but not 
significant reduction of MEK1/2 phosphorylation, both indicating altered intracellular 
signaling caused by the mutant TRα1.  
In summary, marker genes for PV+ and SST+ cells were similarly expressed in juvenile wt 
and TRα1+m mice. Together with the unaltered number of Lhx6 cells in mutant mice we 
concluded, that immature PV cells reach the cortex, but do not undergo the final step of 
maturation. We further observed a reduced expression of NT-3 and phospoAKT in the 
mutant animals and identified a TRα1-TRE interaction in the NT-3 promotor region, 
establishing NT-3 as a novel TRα1 target gene.  
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4 DISCUSSION 
The delayed appearance of PV+ cells in the cortex of TRα1+m mice was the center of my 
PhD thesis. In the following I discuss my results regarding neuronal maturation including 
proliferation, migration, signal transductions regulated by neurotrophins and cortical activity. 
Lastly, I discuss our findings regarding target gene regulation and TREs. 
 
4.1 PROLIFERATION 
TRα1+m mice exert a reduced number of PV expressing cells in the juvenile cortex and a 
prolonged proliferation in the external granular layer of the cerebellum (Venero et al., 2005). 
Hence, we investigated whether TRα1 modulates proliferation. However, TRα1 was absent 
in proliferation sites of the developing brain including the medial ganglionic eminence where 
interneurons are born and proliferate (Marin & Rubenstein, 2003). This was in line with our 
observation in the cerebellum, where TRα1 was not detectable in the external granular layer 
were cells undergo proliferation. However, an involvement of TRα1 in proliferation was 
described earlier in intestinal epithelia cells and optic nerve oligodendrocyte precursor (Billon 
et al., 2002; Plateroti et al., 2006). These diverse findings might be explained by the tissue 
specific functionality of TRs, which was described earlier for hairless and RC3. In the brain 
hairless is responsive to TH whereas in the skin hairless is not inducible by TH (Engelhard & 
Christiano, 2004). Additionally, TH regulates the expression of the TRα1 target gene RC3 in 
a temporal and spatial dependent manner, which was associated to region specific trans-
acting elements (Guadano-Ferraz et al., 1997; Chatonnet et al., 2015). 
In summary, form out data it seems that TRα1 is not involved in cortical interneuron and 
external granular layer proliferation, whereas the proliferation of other cell types is affected 
by TRα1. This can be explained by a cell specific functionality of TRα1.   
 
4.2 INTERNEURON MIGRATION IN THE DEVELOPING CORTEX AND 
CEREBELLUM 
As TRα1 was detected in migrating cells of the developing cortex as well as in migrating 
granule cells of the cerebellum (paper I), we investigated whether TRα1 influences 
interneuron or granule cell migration. 
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In the developing brain TRα1 is expressed in tangentially migrating cells (paper I), which is 
the preferred migration route of immature PV and SST interneurons (Marin & Rubenstein, 
2003). Interestingly, we did not detect an interneuron specific migration failure in TRα1+m 
mice, as the number of cells expressing the PV+ and SST+ cell exclusive marker Lhx6 was 
unaltered in the juvenile brain (paper IV).  This is supported by the unaffected PV+ cell 
migration into the somatosensory cortex of hypothyroid rats (Morte et al., 2002; Auso et al., 
2004). These observations raise the possibility that the unliganded TRα1 is necessary for 
proper migration. In line with this hypothesis, only recently it was postulated that during 
embryogenesis before the onset of endogenous TH production the transcriptional repression 
of the unliganded TRα1 is of greater importance than during postnatal development (Yen, 
2015). This would explain the normal migration of interneuron in TRα1+m mice and during 
hypothyroidism. Moreover, it would be in line with rescuing the delayed appearance of PV+ 
cells by TH treatment from birth on, when the liganded receptor gains more importance 
(Wallis et al., 2008).  
In the postnatal cerebellum cells proliferate in the external granular layer (EGL) before they 
start to migrate postmitotically through the molecular layer into the internal granular layer (in 
adults referred to granular layer). As mentioned above this event is delayed in TRα1+m mice 
(Venero et al., 2005). However proliferation seems not affected by TRα1, hence, we were 
wondering if TRα1 was involved in EGL cell migration. TRα1 was expressed in migrating 
cells as well as in maturing Purkinje cells. As granule cells are the presynaptic partners of 
Purkinje cells it can be speculated that the disturbed granule cell migration in TRα1+m is due 
to failures in Purkinje cell development caused by the mutant TRα1. Although Purkinje cells 
showed no obvious alterations in TRα1+m mice, synapses have not been tested, leaving 
room for speculations (Venero et al., 2005). Recent studies supported the importance of 
proper TRα1 activity for Bergman glia and Purkinje cell development, that in turn affects  
granule cell migration (Fauquier et al., 2014).  
Taken together, in the cortex the unliganded TRα1 does not interfere with proper migration, 
as interneurons reach the cortex in hypothyroid animals as well as in TRα1+m mice. From 
these data we concluded that immature PV cells reach the cortex but are prevented to perform 
the final step of maturation. Further investigations are needed to quantify the number of 
immature PV cells in the mutant and wildtype animals. That can be achieved by combined in 
situ hybridization and immunohistochemistry for Lhx6, SST and PV on wt and TRα1+m 
section.  
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In the contrary, in the cerebellum it is suggested that TRα1 acts via Purkinje cells in early 
development to regulate granule cell migration.  
 
4.3 NEUROTROPHINS 
We could show that immature PV cells reach the cortex in TRα1+m mice but their 
differentiation was blocked by the mutant TRα1. Interstingly, when different factors involved 
in PV+ cell differentiation were investigated, only neurotrophin-3 (NT-3) was found 
dysregulated in the mutants (paper IV). This is line with previous observations, showing that 
NT-3 expression is regulated by TH in vivo and in vitro (Lauterborn et al., 1994; Neveu & 
Arenas, 1996). However, to date it is not clear if the reduced expression of NT-3 is involved 
in the delayed PV+ cell maturation.  
In general, neurotrophins regulate via receptor activation the development of interneurons. 
Neuronal growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin-3 
(NT-3) and neurotrophin-4/5 (NT-4/5) are the members of the neurotrophin family and 
activate receptor tyrosine kinases (TrkA, TrkB, NT-4/5 and TrkC) and the neurotrophin 
receptor p75 (Fig. 8).  
 
                                
Figure 8: Neurotrophins and their receptors. Black arrows: high affinity receptors, grey arrows: lower 
affinity.  
 
Ligand binding leads to transphosphorylation of the Trk receptors and to the activation of one 
of the signaling pathways involved in e.g. cell differentiation (PI3K- MAP kinase pathway), 
cell survival and growth (PI3K - Akt pathway) or synaptic plasticity (plcɣ1 pathway) 
(Vaillant et al., 1999; Reichardt, 2006).   
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Interestingly, several studies have shown that BDNF and NT-4/5 promote PV+ cell 
development via TrkB activation (Patz et al., 2004; Itami et al., 2007), whereas NT-3 did not 
rescue PV+ cell development in organotypical cultures (Patz et al., 2004). Nevertheless, mice 
carrying NT-3 alleles in place of the BDNF alleles could rescue the PV+ cell number in 
BDNF knockout mice (Berghuis et al., 2006). Together with the observed severe phenotype 
of NT-3 knockout mice compared to the rather mild phenotype of TrkC knockouts (NT-3 
receptor), the data indicate that NT-3 is may bind to other receptors and hence, compensate 
for BDNF loss (Coppola et al., 2001). However, in TRα1+m mice a compensatory 
mechanism seems to arise from BDNF-TrkB signaling, as mRNA levels of TrkB were 
elevated at P14 (paper IV).  
Nevertheless, several studies showed an elevated expression of NT-3 in the first postnatal 
week, suggesting a function in cortical maturation (Ernfors et al., 1990; Lauterborn et al., 
1994). Consequently, the reduced NT-3 levels in the mutant mice might indicate a delayed 
developmental increase of NT-3 compared to wt mice. Measurement of NT-3 throughout 
development might help to identify whether the peak of NT-3 expression is delayed or not 
detectable. 
The differentiation of cells expressing both p75 and TrkC were shown to depend on NT-3 
(Simmons et al., 2013). TrkC is only expressed in 12% of adult cortical PV+ cells (Gorba & 
Wahle, 1999). This number does not coincide with the reduction of PV+ cells in our mutant 
mice (Wallis et al., 2008). However, like NT-3, TrkC showed a transiently elevated 
expression during early postnatal development (Ringstedt et al., 1993). This finding is of 
particular interest, since it may indicate that NT-3 –TrkC signaling is involved in early cell 
differentiation. Moreover, the number of TrkC expressing cells during development might be 
higher than in adults, consequently a lack of NT-3 in early development would affect more 
cells than reported in the adults. From that it can be hypothesized that NT-3 regulates cell 
development in a greater extent than suggested in previous reports.  
Not only the cortical signaling is important for PV+ cell development; removal of cortico- 
thalamic connections in cortical cultures led to a delayed PV expression onset but not a loss 
of PV+ cells (Patz et al., 2004), similar to what we have seen in our animal. Interestingly, an 
involvement of NT-3 and its receptor TrkC in afferent innervation has been postulated, as the 
transiently elevated expression of TrkC in the neocortex is accompanied by an increased 
expression of NT-3 in thalamic nuclei. These findings suggested that thalamic NT-3 and 
neocortical TrkC communicate to stabilize cortico-thalamic innervations (Ringstedt et al., 
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1993; Lauterborn et al., 1994). As TRα1 is also expressed in the thalamus (paper I), and 
ChIP assay identified NT-3 as target gene (paper IV), NT-3 might be down regulated in the 
thalamus as well, leading to reduced innervation and hence to a decelerated expression of PV. 
Cortico-thalamic connections were not tested in this study, but need to be followed up to 
further understand the function of NT-3 and TRα1 in innervation.  
However, reduced NT-3 level led to inhibited signal transduction and hence, to reduced 
activation of neurotrophin induced pathways. We identified a reduced phosphorylation of 
AKT at P7, which is involved in cell survival. As discussed in paper IV, the reduced AKT 
phosphorylation might be a mechanism to reduce the increased number of calretinin cells in 
TRα1+m mice. Additionally, we identified a slightly reduced phosphorylation of MEK1/2, 
which is suggested to affect PV+ cell differentiation. Consequently, blocking of MEK2 was 
shown to reduce PV+ cell differentiation in culture (Patz et al., 2004). From that we can 
speculate that the mutant TRα1 affects neurotrophin induced signaling pathways. On one 
hand the mutant receptor inhibits the phosphorylation of AKT leading to reduced cell survival 
and on the other hand it reduces MEK phosphorylation, which inhibits PV+ cell 
differentiation.  
Taking together, even though NT-3 is not the typical neurotrophin involved in PV+ cell 
differentiation, there are several NT-3 dependent mechanisms that modulate PV+ cell 
maturation. In the cortex, the reduced NT-3 levels leads to inhibited signal transduction 
necessary for cell differentiation. In the thalamus, NT-3 is required for proper cortico-
thalamic innervations, which is essential for proper PV+ cell development. Lastly, elevated 
TrkB levels might indicate a compensation mechanism for the delayed PV+ cell 
differentiation.  
 
4.4 CORTICAL ACTIVITY 
Previous studies have revealed the requirement of neuronal activity for neurotrophin and PV 
expression in vitro (Thoenen, 1995; Patz et al., 2004). As carbonic anhydrases (Car) are 
involved in neuronal excitation via buffering the alkaline pH shifts (Chesler, 2003; Shah et 
al., 2005), we speculated that the excitation rate is reduced in TRα1+m mice due to lower 
Car4 levels observed in paper III. This idea is supported by Tang et al. who showed that low 
Car expression reduces seizure susceptibility through the suppression of glutamate receptors 
by an excess of extracellular H+ (Tang et al., 1990).  
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The capability of Car14 to functionally compensate for Car4 absence in the brain was shown 
previously (Shah et al., 2005). Interestingly, Car14 levels are not altered in the mutants 
(observation by Dudazy-Gralla) indicating a normal pH buffering capacity in the cortex. 
However, TRα1+m mice show a reduced seizure susceptibility accompanied by an increased 
expression of the calcium binding protein calretinin in the hippocampus (Hadjab-Lallemend 
et al., 2010). Interestingly, hippocampal GABAergic cells depolarized pyramidal cells upon 
PTZ treatment, indicating an enhanced amount of extracellular HCO3-, which was shown to 
shift the typical GABA induced inhibition to excitation (Kaila & Voipio, 1987; Chesler & 
Kaila, 1992). As Car4 is responsible for dehydrating HCO3-, a lack of Car4 can easily cause 
enrichment. Nevertheless, neurotransmitter and activity-dependent BDNF expression are 
normal in the cortex of mutant mice arguing against a reduced cortical activity (paper IV). 
However more studies are needed to clarify whether cortical activity is disturbed in the 
mutant cortex. Measurement of the inhibitory and excitatory postsynaptical potential may 
contribute to a better understanding of neuronal connectivity. In order to increase excitation 
pharmacologically in vivo, injections with the glutamate analog kainate acid can be 
considered, as it leads to increased excitation resulting in a strong inhibitory response (Ben-
Ari & Cossart, 2000). This treatment should be adequate to provide the putative missing 
excitation when used in lower dosage, as hyperactivation can lead to cell death, similar to 
what we have seen after PTZ injections (paper IV).  
 
4.5 IDENTIFICATION OF TARGET GENES 
Several attempts have been made to find additional TR target genes either by microarray after 
TH treatment or by transfecting tagged-TRs into cell lines followed by TH treatment and 
transcriptom analysis. These experiments revealed over 4000 putative TR target genes, with 
an overlap of only 734 genes between the experiments, depicturing the difficulties to reliable 
identify target genes (Chatonnet et al., 2015). Explanation for the high variety between the 
studies is on the one hand the technical aspects such as TH treatment or statistical analysis. 
On the other hand, target gene regulation differ between cell types, developmental stage and 
is influenced by the altered chromatin structure in cell cultures (Engelhard & Christiano, 
2004; Bernal & Morte, 2013). With our mouse line we can pull down TRα1 specific TREs in 
mouse tissue. In our admittedly exploratory experiments, we identified three novel TRα1 
target genes in the brain and characterized novel TRα1 responsive TREs in heart tissue. 
However, the localization and sequence of the TRE did not allow any conclusions about their 
regulation of transcriptional control, that needed to be tested in vitro and in vivo,  
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With the established ChiP assay we identified two negatively regulated TH target genes: Car4 
and RNF166. Interestingly, the TREs were located in different regions of the respective 
genes, with the TRE of RNF166 in the 3’UTR (untranslated region) and the TRE of Car4 in 
the proximity to the promotor. This is a peculiar finding as it suggests that the direction of 
transregulation is not predictable by the genomic context. Indeed, cistrome analysis revealed 
70% of positively regulated genes contain no TRE in the promotor proximity and binding 
sited were identified upstream and downstream of the promotor (Dong et al., 2009; 
Chatonnet et al., 2013).  
However, the mechanism causing transrepression might depend on TRE localization. 
Consistently, the TRα1 responsive TRE of Car4 was located in the promotor region. Cloning 
of Car4 into a promotor vector led to a reduced luciferase induction upon TH treatment, 
which was in line with in vivo result. On the contrary cloning of the RNF166 TRE into the 
promotor led to transactivation in vitro. From that it can be hypothesized that TREs localized 
in 3’UTR require additional factors to exhibit transrepression (Bigler & Eisenman, 1995), 
which are not available in cell cultures. However, the long distance to the promotor can be 
overcome by chromatin looping, which enables transactivation at long distances. This process 
was shown for other nuclear receptors and was postulated for TRs by Bigler and colleagues 
(Bigler & Eisenman, 1995; Flamant & Gauthier, 2013)  
Taken together, TRE proximity to the promotor does not allow conclusion about target gene 
activation and requires additional in vivo or in vitro experiments after TH level manipulation. 
Long distance between TRE and transcriptional start site can be overcome by chromatin 
looping.  
The advantage of our system when combined with ChiP sequencing compare to the available 
transcriptom analysis is the specific enrichment for TRα1 in vivo, circumventing the need for 
specific TR antibodies and cell culture experiments.  
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5 SUMMARY AND FUTURE PERSPECTIVES 
In my thesis, I describe for the first time the expression pattern of the thyroid hormone 
receptor alpha 1 protein in the developing and mature brain on a cell level. Importantly, our 
discovery that virtually all postmitotic neurons express the receptor clarifies the previously 
long standing question: "in which neurons is TRα1 expressed, and when?". With this 
knowledge, subsequent understanding of, and research into TRα1 action in the brain will be 
significantly simplified.  
In the search for TRα1 target genes we established ChIP assays using TRα1gfp/gfp mice, 
circumventing the need for specific - and not available - TRα1 antibodies. Here, we identified 
RNF166 as novel target genes and discovered TRα1 responsive TREs in the genomic 
sequence of the TH regulated genes Sema3a, HCN2 and HCN4 in heart tissue. The method 
was further utilized to identify carbonic anhydrase 4 (Car4) as novel target gene. We describe 
a tissue specific regulated by TH, with Car4 in lung and brain being dependent on proper 
signaling during early development, whereas renal TH was not affected by the mutant TRα1 
but decreases its expression upon TH treatment. Finally, we discovered that immature PV 
cells are arrested at a late stage of differentiation in the cortex of TRα1 mutant mice. This 
finding was accompanied by a reduced expression of NT-3 and an inhibited phosphorylation 
of its down stream genes, indicating a disturbed intracellular neurotrophin signaling.  
In the future the TRα1-GFP mouse strain may be used to identify further target genes in the 
brain or other tissues, either via individual ChIP assays or untargeted approaches like ChIP 
sequencing. However, the regulation of putative target genes needs to be tested in vivo by 
examination of mRNA levels of the gene of interest, by microarrays or RNA sequencing in 
hypo-, eu- and hyperthyroid animals.  
To identify the role of Car4 in brain maturation and seizure susceptibility in the mutant mice 
the suggested extracellular enrichment of HCO3- needs to be measured in a cell culture 
setting. As the seizure susceptibility was normalized upon TRα1 activation during 
embryogenesis and postnatal live, the same treatment might be sufficient to ameliorate the 
Car4 phenotype. Additionally, overexpression of Car4 might normalize GABA response - 
that was shown to be depolarizing in the hippocampus of TRα1+m mice - and hence alleviate 
the seizure phenotype. Although this proposed role of the downregulation of Car4 may seem 
far reaching, the hypothesis fits with known functions of the involved genes and should 
therefore be tested experimentally. 
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The mechanisms causing the delayed differentiation of PV+ cells needs further 
investigations. To determine whether NT-3 is directly involved in PV+ cell differentiation, 
cortical injecting of an adenoassociated virus (AAV) expressing NT-3 can be considered 
(Boyce et al., 2012). This virus infects neurons at the injection site that will express NT-3. In 
turn, the increased NT-3 levels may induce PV+ cell differentiation. However, how this 
ultimately, through a direct or indirect mechanism, normalizes PV expression requires 
additional experiments, as NT-3 was found to be expressed in pyramidal cells and to a 
smaller extend in interneurons (Pascual et al., 1998; Boukhaddaoui et al., 2001). To address 
the question, I have already cloned the dominant negative TRα1 sequence between lox P sites 
and the vector was linked to an adenoassociated virus construct, intended for studies on 
interneuron specific Cre mouse lines. Using an Lhx6 Cre line, this approach may initiate the 
expression of a dominant negative TRα1 in all maturing SST+ and PV+ interneurons, and in 
case of a cell autonomous should decrease the number of PV+ interneurons. Lastly, in case of 
PV+ cell rescue, assessment of behavior and locomotor might answer the question whether 
the defect in PV+ cell maturation causes the phenotype.  
Further investigation of both mice strains will help to understand the mechanisms involved in 
developmental and adult hypothyroidism. Ultimately, the findings may contribute to identify 
a treatment regime to alleviate the brain retardation and other symptoms described in e.g. 
congenital hypothyroidism or RTHα.  
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